参考文献/References:
[1] Febbraio MA, Pedersen BK. Contraction-induced myokine production and release: is skeletal
muscle an endocrine organ?[J]. Exerc Sport Sci Rev,2005,33(3):114-119.
[2] Raschke S, Eckardt K, Bjørklund Holven K, et al. Identification and validation of
novel contraction-regulated myokines released from primary human skeletal muscle cells[J]. PLoS
One,2013,8(4):e62008.DOI: 10.1371/journal.pone.0062008.
[3] Steensberg A, van Hall G, Osada T,et al. Production of interleukin-6 in contracting human
skeletal muscles can account for the exercise-induced increase in plasma interleukin-6[J]. J
Physiol,2000,529 Pt 1:237-242.
[4] Pedersen BK, Fischer CP. Beneficial health effects of exercise-the role of IL-6 as a
myokine[J]. Trends Pharmacol Sci,2007,28(4):152-156.
[5] Fischer CP. Interleukin-6 in acute exercise and training: what is the biological
relevance?[J]. Exerc Immunol Rev,2006,12:6-33.
[6] Whitham M, Chan MH, Pal M,et al. Contraction-induced interleukin-6 gene transcription in
skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1[J]. J Biol
Chem,2012,287(14):10771-10779. DOI: 10.1074/jbc.M111.310581.
[7] Carey AL, Steinberg GR, Macaulay SL, et al. Interleukin-6 increases insulin-stimulated
glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-
activated protein kinase[J].Diabetes,2006,55(10):2688-2697.
[8] Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C,et al. Dual role of interleukin-6 in
regulating insulin sensitivity in murine skeletal muscle[J].Diabetes,2008,57(12):3211-3221.DOI:
10.2337/db07-1062.
[9] Jiang LQ, Duque-Guimaraes DE, Machado UF, et al. Altered response of skeletal muscle to IL
-6 in type 2 diabetic patients[J].Diabetes,2013,62(2):355-361. DOI: 10.2337/db11-1790.
[10] Ellingsgaard H, Hauselmann I, Schuler B,et al. Interleukin-6 enhances insulin secretion by
increasing glucagon-like peptide-1 secretion from L cells and alpha cells[J].Nat Med,2011,17
(11):1481-1489. DOI: 10.1038/nm.2513.
[11] Izumiya Y, Bina HA, Ouchi N,et al. FGF21 is an Akt-regulated myokine[J].FEBS Lett,2008,582
(27):3805-3810. DOI: 10.1016/j.febslet.2008.10.021.
[12] Keipert S, Ost M, Johann K, et al. Skeletal muscle mitochondrial uncoupling drives
endocrine cross-talk through the induction of FGF21 as a myokine[J].Am J Physiol Endocrinol
Metab, 2014,306(5):E469-E482. DOI: 10.1152/ajpendo.00330.2013.
[13] Kim KH, Jeong YT, Oh H, et al. Autophagy deficiency leads to protection from obesity and
insulin resistance by inducing Fgf21 as a mitokine[J].Nat Med,2013,19(1):83-92. DOI:
10.1038/nm.3014.
[14] Bobbert T, Schwarz F, Fischer-Rosinsky A, et al. Fibroblast growth factor 21 predicts the
metabolic syndrome and type 2 diabetes in Caucasians[J].Diabetes Care,2013,36(1):145-149. DOI:
10.2337/dc12-0703.
[15] Lenart-Lipińska M, Matyjaszek-Matuszek B, Gernand W,et al. Serum fibroblast growth factor
21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2
diabetes at a relatively short-term follow-up[J].Diabetes Res Clin Pract,2013,101(2):194-200.
DOI: 10.1016/j.diabres.2013.04.010.
[16] Li H, Dong K, Fang Q,et al. High serum level of fibroblast growth factor 21 is an
independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China
[J].J Hepatol, 2013,58(3):557-563. DOI: 10.1016/j.jhep.2012.10.029.
[17] Boström P, Wu J, Jedrychowski MP,et al. A PGC1-α-dependent myokine that drives brown
-fat-like development of white fat and thermogenesis[J].Nature,2012,481(7382):463-468. DOI:
10.1038/nature10777.
[18] Huh JY, Panagiotou G, Mougios V,et al. FNDC5 and irisin in humans: Ⅰ. Predictors of
circulating concentrations in serum and plasma and Ⅱ. mRNA expression and circulating
concentrations in response to weight loss and exercise[J].Metabolism,2012,61(12):1725-1738. DOI:
10.1016/j.metabol.2012.09.002.
[19] Piya MK, Harte AL, Sivakumar K, et al. The identification of irisin in human cerebrospinal
fluid: influence of adiposity, metabolic markers, and gestational diabetes[J].Am J Physiol
Endocrinol Metab,2014,306(5):E512-E518. DOI: 10.1152/ajpendo.00308.2013.
[20] Moreno-Navarrete JM, Ortega F, Serrano M,et al. Irisin is expressed and produced by human
muscle and adipose tissue in association with obesity and insulinresistance[J].J Clin Endocrinol
Metab,2013,98(4):E769-E778. DOI: 10.1210/jc.2012-2749.
[21] Lee P, Linderman JD, Smith S,et al. Irisin and FGF21 are cold-induced endocrine activators
of brown fat function in humans[J].Cell Metab,2014,19(2):302-309.DOI:10.1016/j.cmet.2013.12.017.
[22] Sanchis-Gomar F, Perez-Quilis C. The p38-PGC-1α-irisin-betatrophin axis: exploring new
pathways in insulin resistance[J].Adipocyte,2014,3(1):67-68. DOI: 10.4161/adip.27370.
[23] Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived
interleukin-6[J].Physiol Rev,2008,88(4):1379-1406. DOI: 10.1152/physrev.90100.2007.
[24] Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes
mellitus[J].J Diabetes Complications,2013,27(4):365-369. DOI: 10.1016/j.jdiacomp.2013.03.002.
[25] Park KH, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin
resistance and the metabolic syndrome[J].J Clin Endocrinol Metab,2013,98(12):4899-4907. DOI:
10.1210/jc.2013-2373.
[26] Görgens SW, Raschke S, Holven KB,et al. Regulation of follistatin-like protein 1
expression and secretion in primary human skeletal muscle cells[J].Arch Physiol
Biochem,2013,119(2):75-80. DOI: 10.3109/13813455.2013.768270.
[27] Norheim F, Raastad T, Thiede B,et al. Proteomic identification of secreted proteins from
human skeletal muscle cells and expression in response to strength training[J].Am J Physiol
Endocrinol Metab,2011,301(5):E1013-E1021. DOI: 10.1152/ajpendo.00326.2011.
[28] Ouchi N, Oshima Y, Ohashi K,et al. Follistatin-like 1, a secreted muscle protein, promotes
endothelial cell function and revascularization in ischemic tissue through a nitric-oxide
synthase-dependent mechanism[J].J Biol Chem,2008,283(47):32802-32811. DOI:
10.1074/jbc.M803440200.
[29] Ogura Y, Ouchi N, Ohashi K, et al. Therapeutic impact of follistatin-like 1 on myocardial
ischemic injury in preclinical models[J].Circulation,2012,126(14):1728-1738.
DOI:10.1161/CIRCULATIONAHA.112.115089.
[30] Rothman SM, Griffioen KJ, Wan R,et al. Brain-derived neurotrophic factor as a regulator of
systemic and brain energy metabolism and cardiovascular health[J].Ann N Y Acad Sci,2012,1264:49
-63. DOI: 10.1111/j.1749-6632.2012.06525.x.
[31] Dupont-Versteegden EE, Houlé JD, Dennis RA, et al. Exercise-induced gene expression in
soleus muscle is dependent on time after spinal cord injury in rats[J].Muscle Nerve,2004,29
(1):73-81.
[32] Matthews VB, Aström MB, Chan MH, et al. Brain-derived neurotrophic factor is produced
by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of
AMP-activated protein kinase[J].Diabetologia,2009,52(7):1409-1418. DOI: 10.1007/s00125-009-1364
-1.
[33] Szuhany KL, Bugatti M, Otto MW. A meta-analytic review of the effects of exercise on brain
-derived neurotrophic factor[J].J Psychiatr Res,2015,60:56-64. DOI:
10.1016/j.jpsychires.2014.10.003.
[34] Ola MS, Nawaz MI, El-Asrar AA,et al. Reduced levels of brain derived neurotrophic factor
(BDNF)in the serum of diabetic retinopathy patients and in the retina of diabetic rats[J].Cell
Mol Neurobiol,2013,33(3):359-367. DOI: 10.1007/s10571-012-9901-8.